Page 120 - book
P. 120
Product List IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Dosage
Type Product Strength Indication Status
form
Preventing blood clots and Stroke in patients with atrial
Oral Xabano 2.5 Tablet 2.5mg Marketed
fibrillation (A disturbance in heart rhythm)
Preventing blood clots and Stroke in patients with atrial
Oral Xabano 5 Tablet 5mg Marketed
fibrillation (A disturbance in heart rhythm)
tablet is used to treat type 2 diabetes in adult patients
Oral Paglino 10 Tablet 10mg (aged 18 years and older) that cannot be controlled by Marketed
diet and exercise alone
tablet is used to treat type 2 diabetes in adult patients
Oral Paglino 25 Tablet 25mg (aged 18 years and older) that cannot be controlled by Marketed
diet and exercise alone
is recommended for the treatment of rheumatic and
autoimmune diseases(e.g. myositis), skin ( e.g. pemphi-
Oral Fortydex 4 Tablet 4mg Marketed
gus vulgaris ) diseases of blood, treatment of symptom-
atic multiple myeloma,
is recommended for the treatment of rheumatic and
autoimmune diseases(e.g. myositis), skin ( e.g. pemphi-
Oral Fortydex 40 Tablet 40mg Marketed
gus vulgaris ) diseases of blood, treatment of symptom-
atic multiple myeloma
to improve motor symptoms in multiple sclerosis
Extended (MS) patient with walking problem. multiple sclerosis
Oral Dalfyra release 10mg causes the destruction of protective sheath around the Marketed
tablet nerve cell and leads to muscle stiffness and difficulty in
walking
is iron chelator used to treat ongoing high levels of iron
Oral NanoJade 90 Tablet 90mg Marketed
in the body
is iron chelator used to treat ongoing high levels of iron
Oral NanoJade 180 Tablet 180mg Marketed
in the body
is iron chelator used to treat ongoing high levels of iron
Oral NanoJade 360 Tablet 360mg Marketed
in the body
Is a herbal drug containing Mellilotus Officinalis dried
Oral Angipars Capsule 100mg extract and is effective in the treatment of diabetic foot Marketed
ulcers and diabetic peripheral neuropathy 119
you can find the rest of the product list on page 275